Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
11/09/2026 21:25
BRIEF-Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Sept 11 (Reuters) - Korro Bio, Inc. KRRO.O:
KORRO BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNXXYqVH
Further company coverage: KRRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview